Alembic's Q4 FY 2025-26 Quarterly Results

Result Summary

• Alembic Ltd reported a 18.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 1.7%.
• Its expenses for the quarter were down by 14.0% QoQ and up 20.5% YoY.
• The net profit increased 11.6% QoQ and decreased 1.9% YoY.
• The earnings per share (EPS) of Alembic Ltd stood at 2.61 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Alembic Ltd is a well-established pharmaceutical company, primarily engaged in the manufacture and marketing of generic pharmaceuticals and active pharmaceutical ingredients. The company operates in the healthcare sector, providing a wide range of pharmaceutical products. Alembic Ltd has a global presence, with a strong focus on research and development to support its product pipeline. In recent times, the company has been focusing on expanding its product portfolio and enhancing its manufacturing capabilities to strengthen its market position. However, specific recent developments or strategic initiatives for Alembic Ltd are not available based on the current data.

Revenue

During the fourth quarter of the fiscal year 2026 (Q4FY26), Alembic Ltd reported a total income of ₹62.18 crores. This represents a sequential decrease of 18.9% compared to the third quarter of fiscal year 2026 (Q3FY26), where the total income was ₹76.65 crores. On a year-over-year basis, comparing Q4FY26 to the fourth quarter of fiscal year 2025 (Q4FY25), total income saw a slight decline of 1.7%, down from ₹63.23 crores. This data indicates a decrease in revenue both sequentially and annually, highlighting the fluctuations in the company's income over the specified periods.

Profitability

Alembic Ltd's profitability metrics for Q4FY26 reveal some significant changes. The profit before tax (PBT) for Q4FY26 was ₹18.44 crores, marking a substantial decline of 28.4% from Q3FY26, where the PBT was ₹25.76 crores. Compared to Q4FY25, there was a decrease of 31.5% from ₹26.92 crores. The tax expense for Q4FY26 was ₹8.83 crores, which increased by 168.4% quarter-over-quarter from ₹3.29 crores in Q3FY26 and by 178.5% year-over-year from ₹3.17 crores in Q4FY25. Despite these changes, the profit after tax (PAT) for Q4FY26 was ₹67.13 crores, which is an increase of 11.6% from the previous quarter's ₹60.13 crores, though slightly down by 1.9% from ₹68.45 crores in Q4FY25. Earnings per share (EPS) also rose to ₹2.61 in Q4FY26, reflecting an 11.5% increase from Q3FY26, while showing a minor decrease of 2.2% compared to Q4FY25.

Operating Metrics

The total expenses for Alembic Ltd in Q4FY26 were reported at ₹43.74 crores, marking a decrease of 14.0% from the previous quarter's expenses of ₹50.89 crores. However, when compared to the same quarter in the previous fiscal year (Q4FY25), there was an increase of 20.5% from ₹36.31 crores. This indicates a variation in the cost structure over the different periods. The company's profitability and expenses data reveal the operational dynamics affecting its financial performance during the specified quarters and fiscal years.